Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Growth Opportunities are Expected to Drive the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market’s CAGR Through 2034?
The market for ribose-nucleic acid (RNA)-based therapies has seen robust growth in recent years. The market, which is expected to expand from $15.79 billion in 2024 to $17.26 billion in 2025, is projected to witness a compound annual growth rate (CAGR) of 9.3%. The growth experienced in the past years can be credited to an increase in investment and funding, the discovery of RNA interference (RNAi), clinical triumphs of antisense oligonucleotides (ASOs), favorable regulatory frameworks, and a surge in collaborations and partnerships.
Expectations are high for significant expansion in the ribose-nucleic acid (RNA)-based therapeutics market over the coming years. The projected growth rate is an impressive 8.9% compounded annually, culminating in a market worth $24.26 billion in 2029. This anticipated growth can be linked to factors such as the broadening of indications, accelerating market demand, increased adoption, regulatory backing, the inclusion of artificial intelligence (AI) and machine learning, as well as new applications in the treatment of rare diseases. Key trends for this period include the development of advanced delivery systems, RNA therapeutics targeting multiple areas, personalized RNA treatments, advances in regulations, and the commercial growth and acceleration of the market.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The escalating occurrence of cancer is anticipated to drive the advancement of the ribose-nucleic acid (RNA)-based therapeutics market in the future. Cancer is a disease marked by the unregulated growth and spread of abnormal cells, potentially fatal if not treated. With an aging population, lifestyle modifications, higher risk exposure, and advanced detection methods, cancer prevalence continues to rise. RNA-based therapeutics provide a beneficial approach for tackling cancer, focusing directly on its genetic and molecular causes. For instance, a report by the Australian Institute of Health and Welfare in August 2023 highlighted that an estimated 151,000 people were diagnosed with cancer (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021 in Australia. This number is projected to rise to 185,000 in 2030. Hence, the continual increase in cancer cases is propelling the growth of the ribose-nucleic acid (RNA)-based therapeutics market.
Get Your Free Sample of the Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=18454&type=smp
What Are the Leading Industry Players Dominating the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are:
• F. Hoffmann-La Roche AG
• Eli Lilly and Company
• Novo Nordisk A/S
• Regeneron Pharmaceuticals
• Biogen Inc.
What Are the Latest Trends Leading to Disruption in the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
Key players in the ribose nucleic acid (RNA)-focused therapy market are aiming to create innovative therapeutics like messenger RNA (mRNA)-centered booster shots, with the goal to improve immunization efficiency, address new viral mutations, and amplify the overall strength of vaccine-induced immunity. mRNA-based booster vaccines use mRNA to cause cells to produce a protein that heightens the body’s immune resistance to a specific pathogen. For example, in June 2023, Gennova Biopharmaceuticals Ltd., a pharmaceutical firm based in India, unveiled GEMCOVAC-OM, marking India’s debut mRNA booster vaccine designed for the Omicron variant of COVID-19 specifically. This booster has gained importance due to the limited effectiveness of initial vaccines in combating Omicron. By leveraging mRNA science, GEMCOVAC-OM boosts immunity and provides superior defense against the continually mutating virus.
Get Instant Access to the Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report with Swift Delivery!
What Major Market Segments Define the Scope and Growth of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
The ribose-nucleic acid (RNA)-based therapeutics market covered in this report is segmented –
1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Which Regions Are Significant to the Growth of the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?
North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can We Define the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market and Its Key Components?
The ribose-nucleic acid (RNA)-based therapeutics refer to a class of medical treatments that utilize ribose-nucleic acid (RNA) molecules to influence cellular processes, typically by targeting specific genetic sequences. These therapies are designed to treat various conditions, including genetic disorders, cancers, and infectious diseases, by modulating gene expression, protein production, or cellular signaling pathways.
Browse Through More Similar Reports By The Business Research Company:
Nucleic Acid Based Gene Therapy Global Market Report 2024
Nucleic Acid Labeling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Space Militarization Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/space-militarization-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
